ALFA Filings
Every announcement, straight from the exchange
Every QMS Medical Allied Services earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Q1 FY27 saw 22% YoY revenue growth driven by service expansion. Successful migration to NSE main board and planned 100% acquisition of Saarathi Healthcare highlight strategic scale-up in Patient Support Programs (PSP).
QMS delivered strong Q1FY27 performance with 22% YoY revenue growth. Strategy focuses on scaling Services (Patient Support Programs) and expanding proprietary Q-Devices portfolio.
QMS Medical Allied Services delivered ₹172.9cr revenue (11% YoY growth) in FY26, driven by a shift toward high-margin patient support services despite margin compression from strategic front-loaded investments.
QMS reports FY26 revenue of ₹172.9 Cr, up 11% YoY, driven by services expansion and the Saarathi Healthcare integration. The company is pivoting towards high-growth Patient Support Programs (PSP).